Expertise in
26
conditions

Dr. Uday Shankar

Gastroenterology
Centerpoint Gastroenterology & Hepatology-Winchester
225 Hospital Dr Ste 315, 
Winchester, KY 
Expertise in
26
conditions
Centerpoint Gastroenterology & Hepatology-Winchester
225 Hospital Dr Ste 315, 
Winchester, KY 

Overview

Uday Shankar is a Gastroenterologist practicing medicine in Winchester, Kentucky.

Dr. Shankar is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Visceromegaly, Anemia, Nonalcoholic Steatohepatitis (NASH), Endoscopy, and Gastrectomy.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 6 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in KY

Hospital Affiliations

Saint Mary's Hospital
Clark Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Centerpoint Gastroenterology & Hepatology-Winchester
225 Hospital Dr Ste 315, Winchester, KY 40391

Additional Areas of Focus

Dr. Shankar has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

12 Total Publications

Through-the-Scope Suturing for Late-Onset Fistula Closure in the Setting of Bariatric Surgery.
Through-the-Scope Suturing for Late-Onset Fistula Closure in the Setting of Bariatric Surgery.
Journal: The American surgeon
Published: November 15, 2023
Similar Doctors
Expertise in
21
conditions
Dr. Houssam Mardini
Gastroenterology
Expertise in
21
conditions
Dr. Houssam Mardini
Gastroenterology
Referral may be required

Kentucky Children's Hospital

800 Rose St, 
Lexington, KY 
 (16.1 miles away)
859-323-5000
Languages Spoken:
English
See accepted insurances

Houssam Mardini is a Gastroenterologist practicing medicine in Lexington, Kentucky. Dr. Mardini is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Cholestasis, Bile Duct Obstruction, Bile Duct Stricture, Endoscopy, and Pancreatectomy.

Expertise in
44
conditions
Dr. Adalberto Castellanos
Gastroenterology
Expertise in
44
conditions
Dr. Adalberto Castellanos
Gastroenterology
Referral may be required

Office

1780 Nicholasville Rd Ste 202, 
Lexington, KY 
 (17.4 miles away)
859-260-5051
Languages Spoken:
English
See accepted insurances

Adalberto Castellanos is a Gastroenterologist practicing medicine in Lexington, Kentucky. Dr. Castellanos is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Lower Esophageal Ring, Benign Esophageal Stricture, Painful Swallowing, Swallowing Difficulty, and Endoscopy.

Expertise in
11
conditions
Dr. Jens Rosenau
Gastroenterology
Expertise in
11
conditions
Dr. Jens Rosenau
Gastroenterology
Referral may be required

University Of Kentucky

Lexington, KY 
 (16.5 miles away)
859-323-6700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jens Rosenau is a Gastroenterologist practicing medicine in Lexington, Kentucky. Dr. Rosenau is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Visceromegaly, Endoscopy, and Liver Transplant.

Frequently Asked Questions about Dr. Uday Shankar

How do I make an appointment with Dr. Uday Shankar?

You can book an appointment with Dr. Uday Shankar by calling their office at 859-744-5757. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Uday Shankar a top-rated expert for Visceromegaly?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Uday Shankar is classified as an Distinguished expert for Visceromegaly, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Uday Shankar specialize in?

While Dr. Uday Shankar is a Gastroenterology, they have specific expertise in Visceromegaly, Anemia, and Nonalcoholic Steatohepatitis (NASH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Uday Shankar participate in research or clinical trials?

Yes. Dr. Uday Shankar has published 12 articles and abstracts on conditions like Visceromegaly. You can view a list of Dr. Uday Shankar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Uday Shankar accept my insurance?

Dr. Uday Shankar accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 859-744-5757 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shankar's expertise for a condition
ConditionClose
    View All 24 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile